Topical estrogens combined with argon plasma coagulation in the management of epistaxis in hereditary hemorrhagic telangiectasia.
The aim of this study was to assess the value of topically applied estrogens in patients with hereditary hemorrhagic telangiectasia. Twenty-six patients with this disorder were treated with argon plasma coagulation and randomized into 2 groups: group A, which had postoperative application of estriol ointment (n = 14), and group B, which had postoperative application of dexpanthenol ointment (n = 12). Over a period of 12 months, the frequency and intensity of bleeding, the patient's satisfaction, and the success of the treatment were evaluated with a questionnaire. Before the operation, more than 90% of the patients in both groups complained of daily episodes of epistaxis. Twelve months after treatment, the frequency and intensity of bleeding had significantly decreased in group A as compared to group B. Of the patients in group A, 93% were satisfied with the treatment. Of the patients in group B, only 42% were satisfied with the treatment. In both groups, more than 90% of the patients were willing to undergo the same treatment again. The combined treatment approach with argon plasma coagulation and topical estriol enables us to significantly prolong the hemorrhage-free interval.
Bergler
Wolfgang
W
From the Department of Otolaryngology-Head and Neck Surgery, University Hospital Mannheim, Mannheim, Germany.
Sadick
Haneen
H
Gotte
Karl
K
Riedel
Frank
F
Hörmann
Karl
K
D000281:Administration, Intranasal; D000293:Adolescent; D000328:Adult; D000368:Aged; D001128:Argon; D017024:Chemotherapy, Adjuvant; D002648:Child; D016903:Drug Monitoring; D004844:Epistaxis / Q000097:blood / Q000453:epidemiology / Q000235:genetics* / Q000628:therapy*; D004964:Estriol / Q000008:administration & dosage* / Q000097:blood; D005260:Female; D006801:Humans; D015994:Incidence; D017075:Laser Coagulation / Q000295:instrumentation / Q000379:methods* / Q000523:psychology; D008297:Male; D008875:Middle Aged; D009824:Ointments; D010205:Pantothenic Acid / Q000008:administration & dosage* / Q000031:analogs & derivatives; D017060:Patient Satisfaction; D011182:Postoperative Care / Q000379:methods; D011446:Prospective Studies; D012008:Recurrence; D012720:Severity of Illness Index; D011795:Surveys and Questionnaires; D013683:Telangiectasia, Hereditary Hemorrhagic / Q000150:complications* / Q000175:diagnosis; D016896:Treatment Outcome
D009824:Ointments; D010205:Pantothenic Acid; C007288:dexpanthenol; D001128:Argon; D004964:Estriol